Vimarsana
Biggest News Aggregation in the World

Page 3 - Scotta Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scotta Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scotta Smith Today - Breaking & Trending Today

Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023 - Vimarsana News

Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S....

Viatris to sell several business segments for almost $7 billion - Vimarsana News

Viatris to sell several business segments for almost $7 billion

Pharmaceuticals giant Viatris Inc. said Monday it has agreed to sell several business segments in a planned divestiture. The Cecil-based company will sell substantially all of its Over-the-Counter (OTC) business, Women’s Healthcare business, Active Pharmaceutical Ingredients business in India. The company is also selling commercialization rights that were acquired when

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA - Vimarsana News

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA

Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously Communicated RangeStrategic Decision Made to Retain Rights...

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA - Vimarsana News

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA

Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line...

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA - Vimarsana News

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA

Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously...